Entries by mercuric

MErCuRIC exhibits at PPI Strategy launch, Belfast

Information about PPI in the MErCuRIC study was displayed at a public event launching the NI Cancer Trials Network (NICTN) and NI Cancer Research Consumer Forum (NICRCF) new 5 year Strategy for Personal and Public Involvement in Cancer Research in Northern Ireland.  Around 85 research staff, patient representatives and members of the public attended the […]

#mybest10seconds campaign

On the 28th of February 2019, EuropaColon/Digestive Cancers Europe (DICE), one of MErCuRIC’s Related Organisations launched a pan European Colorectal Cancer Screening Awareness Campaign: #mybest10seconds #ECCAM2019. The aim of the campaign is to reach as many citizens across Europe in order to promote the importance of colorectal cancer screening for those over 50 years of […]

MErCuRIC Coordinator joins forces for Bowel Cancer Awareness Month 2019

Prof. Sandra Van Schaeybroeck from Queen’s University Belfast, the Coordinator of the MErCuRIC project will join researchers involved in the COLOSSUS Project to facilitate a public forum in Dublin on 30 April 2019. In Ireland, April is “Bowel Cancer Awareness Month”. The event: “Colorectal Cancer- How is research in Ireland addressing the challenges?” will take place at […]

Partner UNITO adds to MErCuRIC list of publications

Two new research studies with acknowledgement to MErCuRIC have recently been published by our partners at the University of Torino (UNITO): Truini A, Germano G, Bardelli A. Inactivation of DNA repair-prospects for boosting cancer immune surveillance. Genome Med. 2018 Nov 28;10(1):91. doi: 10.1186/s13073-018-0603-9. PubMed PMID: 30486892; PubMed Central PMCID: PMC6260742. Germano G, Amirouchene-Angelozzi N, Rospo G, […]

MErCuRIC progress and goals elucidated at EORTC-NCI-AACR Symposium

MErCuRIC Coordinator Prof Sandra Van Schaeybroeck (QUB) and PI Prof Richard Wilson (BHSCT) presented recent project findings at the EORTC NCI AACR symposium in Dublin. This year’s meeting theme was “Molecular Targets and Cancer Therapeutics”. The research poster entitled “MErCuRIC1: A phase 1 Multi-Centre Study of Crizotinib (cMET inhibitor) Combined with Binimetinib (MEK1/2 inhibitor) in […]

MErCuRIC consortia meeting hosted by UNITO, Month 60

The MErCuRIC team of researchers assembled for the Month 60 plenary meeting on November 8th and 9th in Italy. On the 8th the group was met at the Candiolo Cancer Institute (IRCCS) and on the 9th at the Molecular Biotechnology Center of the University of Torino (UNITO). After an overview and report on the project progress […]

Ed Goodall, NICRCF reports as a EuropaColon Patient Advisor

Northern Ireland Cancer Research Consumer Forum (NICRCF) member, Ed Goodall, was elected in 2018 to the Patient Advisory Group of the EuropaColon organisation which incorporates researchers and healthcare professionals from nearly 40 countries. The EuropaColon Patient Advisory Group held their most recent meeting in October 2018 in Munich in conjunction with that of the European Society […]

Cancer researchers at Queen’s University Belfast win European Health Award

Cancer researchers at Queen’s University Belfast and the University of Leeds, as part of a pan-European partnership, called the European Cancer Concord (ECC) won the prestigious 2018 European Health Award. MErCuRIC PI Professor Mark Lawler, Chair in Translational Cancer Research at Queen’s University Belfast and Vice President of ECC, received the award on October 3, […]

Masarykova Univerzita partners present MErCuRIC at ECCB 2018 in Athens

Partners Dr Vlad Popovici and Anna Pečinková, Faculty of Informatics, Research Centre for Toxic Compounds in the Environment (RECETOX), Masarykova Univerzita presented MErCuRIC research, “Cross-platform gene expression signature for microsatellite instability in colon and gastric cancers” at the European Conference on Computational Biology (ECCB) 2018 in Athens, Greece. The conference was held September 8- 12, 2018. ECCB […]

QUB Prof Richard Wilson will present MErCuRIC at the EORTC-NCI-AARC Symposium

On November 16, 2018, MErCuRIC PI, Professor Richard Wilson of Queen’s University Belfast will present “A phase I dose escalation multi-centre study crizotinib (MET inhibitor) in patients with advanced solid tumours” during a “Molecular Targeted Agents” session of the EORTC-NCI-AACR Symposium. The meeting will take place on 13-16 November 2018 in The Convention Centre Dublin, in the Republic of […]